The evolution of drug regulatory sciences in the Netherlands: 15 years of follow-up

In the Netherlands drug regulatory science is a vibrant national and internationally oriented community. In this review we present the factors that have contributed to this successful collaboration between relevant stakeholders, and that led to a surge of activities around how regulatory science became embedded in the ecosystem of medicines research, clinical pharmacology, policy making and regulation. We distinguished three pivotal episodes: 1) TI Pharma Escher-project, 2) Dutch Medicines Evaluation Board as catalyst of the big jump, 3) Regulatory Science Network Netherlands and multistakehol... Mehr ...